Recent advances in therapeutic chalcones

被引：183

作者：

Ni, LM ^{[1
]}

Meng, CQ ^{[1
]}

Sikorski, JA ^{[1
]}

机构：

[1] AtheroGenet Inc, Alpharetta, GA 30004 USA

来源：

EXPERT OPINION ON THERAPEUTIC PATENTS | 2004年 / 14卷 / 12期

关键词：

1,3-diphenyl-2-propen-1-one; alpha; beta-unsaturated ketone; antibacterial; anticancer; anti-infective; anti-inflammatory; antimalarial; antioxidant; chalcone;

D O I：

10.1517/13543776.14.12.1669

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Naturally-occurring and synthetic chalcone compounds have shown promising biological activity and safety profiles and have the potential to be developed as, or more properly, serve as lead compounds for, the discovery of antioxidant, anti-inflammatory, anticancer or anti-infective agents. Mechanisms of the diverse activities observed with chalcone compounds are not well-defined. This review highlights recent developments and patent activities of chalcones with various therapeutic properties.

引用

收藏

页码：1669 / 1691

页数：23

相关论文

共 128 条

[71] Antimalarial alkoxylated and hydroxylated chalones: Structure-activity relationship analysis [J].

Liu, M ;

Wilairat, P ;

Go, ML .

JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (25) :4443-4452

[72] 2′-Hydroxychalcone inhibits nuclear factor-κB and blocks tumor necrosis factor-α- and lipopolysaccharide-induced adhesion of neutrophils to human umbilical vein endothelial cells [J].

Madan, B ;

Batra, S ;

Ghosh, B .

MOLECULAR PHARMACOLOGY, 2000, 58 (03) :526-534

[73] Artery relaxation by chalcones isolated from the roots of Angelica keiskei [J].

Matsuura, M ;

Kimura, Y ;

Nakata, K ;

Baba, K ;

Okuda, H .

PLANTA MEDICA, 2001, 67 (03) :230-235

[74] Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-α-induced VCAM-1 expression [J].

Meng, CQ ;

Zheng, XS ;

Ni, LM ;

Ye, ZH ;

Simpson, JE ;

Worsencroft, KJ ;

Hotema, MR ;

Weingarten, MD ;

Skudlarek, JW ;

Gilmore, JM ;

Hoong, LK ;

Hill, RR ;

Marino, EM ;

Suen, KL ;

Kunsch, C ;

Wasserman, MA ;

Sikorski, JA .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (06) :1513-1517

[75]

Middleton E, 2000, PHARMACOL REV, V52, P673

[76]

MINOPHAGEN PHARM CO, 1999, Patent No. 11349521

[77] Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa 1c1c7 cells [J].

Miranda, CL ;

Aponso, GLM ;

Stevens, JF ;

Deinzer, ML ;

Buhler, DR .

CANCER LETTERS, 2000, 149 (1-2) :21-29

[78] Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro [J].

Miranda, CL ;

Stevens, JF ;

Ivanov, V ;

McCall, M ;

Frei, B ;

Deinzer, ML ;

Buhler, DR .

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2000, 48 (09) :3876-3884

[79]

Moll UM, 2003, MOL CANCER RES, V1, P1001

[80] Synthesis and biological activities of fluorinated chalcone derivatives [J].

Nakamura, C ;

Kawasaki, N ;

Miyataka, H ;

Jayachandran, E ;

Kim, IH ;

Kirk, KL ;

Taguchi, T ;

Takeuchi, Y ;

Hori, H ;

Satoh, T .

BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (03) :699-706

← 3 4 5 6 7 8 9 10 11 12 →